| Dr Charles B Mormando, DO | |
|
2501 N 3rd St, Harrisburg, PA 17110 | |
| (717) 782-4734 | |
| (717) 782-4727 |
| Full Name | Dr Charles B Mormando |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 11 Years |
| Location | 2501 N 3rd St, Harrisburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366853624 | NPI | - | NPPES |
| 1035174690001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | OS019370 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Milton S Hershey Medical Center Physicians Group | 3870405483 | 1400 |
News Archive
Writing in the Huffington Post's "Impact" blog in advance of the Monitoring & Evaluation Reference Group (MERG) meeting convened by the Roll Back Malaria Partnership and taking place in Namibia this week, Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, interviews Roly Gosling, current head of the Malaria Elimination Initiative at the University of California, San Francisco, "regarding malaria elimination, its importance, and why the Global Fund is critical to achieving that goal worldwide."
Alectos Therapeutics Inc. today announced a research collaboration with Merck, headquartered in Whitehouse Station, N.J., to identify and develop compounds that modulate O-linked N-acetylglucosaminidase (O-GlcNAcase) an enzyme that is believed to be involved in the development of Alzheimer's disease and potentially other disorders. The agreement provides Merck with a worldwide, exclusive license to research, develop and commercialize compounds that modulate this target.
Patient history and physical examination, traditionally the cornerstone diagnostic tool for medical care, may still be among the most accurate and cost-efficient methods to assess patients with congestive heart failure, UT Southwestern Medical Center researchers have found.
A study in mice shows how a breakdown of the brain's blood vessels may amplify or cause problems associated with Alzheimer's disease. The results published in Nature Communications suggest that blood vessel cells called pericytes may provide novel targets for treatments and diagnoses.
The EU Commission has launched a study on the economic and technical evolution of the scientific publication markets in Europe, the results of which will be available in 2005. The objective is to determine the conditions required for optimum operation of the sector and to assess the extent to which the Commission can help to meet those conditions.
› Verified 2 days ago
| Entity Name | The Milton S Hershey Medical Center Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710951744 PECOS PAC ID: 3870405483 Enrollment ID: O20040225000741 |
News Archive
Writing in the Huffington Post's "Impact" blog in advance of the Monitoring & Evaluation Reference Group (MERG) meeting convened by the Roll Back Malaria Partnership and taking place in Namibia this week, Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, interviews Roly Gosling, current head of the Malaria Elimination Initiative at the University of California, San Francisco, "regarding malaria elimination, its importance, and why the Global Fund is critical to achieving that goal worldwide."
Alectos Therapeutics Inc. today announced a research collaboration with Merck, headquartered in Whitehouse Station, N.J., to identify and develop compounds that modulate O-linked N-acetylglucosaminidase (O-GlcNAcase) an enzyme that is believed to be involved in the development of Alzheimer's disease and potentially other disorders. The agreement provides Merck with a worldwide, exclusive license to research, develop and commercialize compounds that modulate this target.
Patient history and physical examination, traditionally the cornerstone diagnostic tool for medical care, may still be among the most accurate and cost-efficient methods to assess patients with congestive heart failure, UT Southwestern Medical Center researchers have found.
A study in mice shows how a breakdown of the brain's blood vessels may amplify or cause problems associated with Alzheimer's disease. The results published in Nature Communications suggest that blood vessel cells called pericytes may provide novel targets for treatments and diagnoses.
The EU Commission has launched a study on the economic and technical evolution of the scientific publication markets in Europe, the results of which will be available in 2005. The objective is to determine the conditions required for optimum operation of the sector and to assess the extent to which the Commission can help to meet those conditions.
› Verified 2 days ago
| Entity Name | Pennsylvania Psychiatric Institute |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1881829976 PECOS PAC ID: 3870678915 Enrollment ID: O20091112000465 |
News Archive
Writing in the Huffington Post's "Impact" blog in advance of the Monitoring & Evaluation Reference Group (MERG) meeting convened by the Roll Back Malaria Partnership and taking place in Namibia this week, Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, interviews Roly Gosling, current head of the Malaria Elimination Initiative at the University of California, San Francisco, "regarding malaria elimination, its importance, and why the Global Fund is critical to achieving that goal worldwide."
Alectos Therapeutics Inc. today announced a research collaboration with Merck, headquartered in Whitehouse Station, N.J., to identify and develop compounds that modulate O-linked N-acetylglucosaminidase (O-GlcNAcase) an enzyme that is believed to be involved in the development of Alzheimer's disease and potentially other disorders. The agreement provides Merck with a worldwide, exclusive license to research, develop and commercialize compounds that modulate this target.
Patient history and physical examination, traditionally the cornerstone diagnostic tool for medical care, may still be among the most accurate and cost-efficient methods to assess patients with congestive heart failure, UT Southwestern Medical Center researchers have found.
A study in mice shows how a breakdown of the brain's blood vessels may amplify or cause problems associated with Alzheimer's disease. The results published in Nature Communications suggest that blood vessel cells called pericytes may provide novel targets for treatments and diagnoses.
The EU Commission has launched a study on the economic and technical evolution of the scientific publication markets in Europe, the results of which will be available in 2005. The objective is to determine the conditions required for optimum operation of the sector and to assess the extent to which the Commission can help to meet those conditions.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles B Mormando, DO Po Box 858, Mc A410, Hershey, PA 17033-0858 Ph: (800) 243-1455 | Dr Charles B Mormando, DO 2501 N 3rd St, Harrisburg, PA 17110 Ph: (717) 782-4734 |
News Archive
Writing in the Huffington Post's "Impact" blog in advance of the Monitoring & Evaluation Reference Group (MERG) meeting convened by the Roll Back Malaria Partnership and taking place in Namibia this week, Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, interviews Roly Gosling, current head of the Malaria Elimination Initiative at the University of California, San Francisco, "regarding malaria elimination, its importance, and why the Global Fund is critical to achieving that goal worldwide."
Alectos Therapeutics Inc. today announced a research collaboration with Merck, headquartered in Whitehouse Station, N.J., to identify and develop compounds that modulate O-linked N-acetylglucosaminidase (O-GlcNAcase) an enzyme that is believed to be involved in the development of Alzheimer's disease and potentially other disorders. The agreement provides Merck with a worldwide, exclusive license to research, develop and commercialize compounds that modulate this target.
Patient history and physical examination, traditionally the cornerstone diagnostic tool for medical care, may still be among the most accurate and cost-efficient methods to assess patients with congestive heart failure, UT Southwestern Medical Center researchers have found.
A study in mice shows how a breakdown of the brain's blood vessels may amplify or cause problems associated with Alzheimer's disease. The results published in Nature Communications suggest that blood vessel cells called pericytes may provide novel targets for treatments and diagnoses.
The EU Commission has launched a study on the economic and technical evolution of the scientific publication markets in Europe, the results of which will be available in 2005. The objective is to determine the conditions required for optimum operation of the sector and to assess the extent to which the Commission can help to meet those conditions.
› Verified 2 days ago
Dr. Valentyna Honchar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4250 Crums Mill Rd Ste 102, Harrisburg, PA 17112 Phone: 717-649-0211 Fax: 206-895-7032 | |
Dr. Yassir Osama Mahgoub, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2501 North Third St, Harrisburg, PA 17110 Phone: 717-782-6420 Fax: 717-782-4727 | |
Dr. Daisy Shirk, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2501 N 3rd St, Harrisburg, PA 17110 Phone: 717-782-4734 Fax: 717-782-4727 | |
Rahat Taswir, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2209 Forest Hills Dr, Suite 19, Harrisburg, PA 17112 Phone: 717-540-4420 Fax: 717-540-4427 | |
Nuzhat Kausar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2595 Interstate Dr, Suite 103, Harrisburg, PA 17110 Phone: 800-370-3651 Fax: 860-510-0020 | |
Ray E Sharretts, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 409 S 2nd St, Suite 3f, Harrisburg, PA 17104 Phone: 717-123-0345 Fax: 717-230-3411 | |
Paul A Conti, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 307 S Front St, Harrisburg, PA 17104 Phone: 717-221-6200 Fax: 717-221-6208 |